Gerstein Fisher’s Allergan plc AGN Stock Holding History

Gerstein Fisher’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$4.38M	Sell	19,009 -301	-2%	-$73.6K	0.54%	30
2016 Q2	$4.46M	Sell	19,310 -1,054	-5%	-$243K	0.58%	29
2016 Q1	$5.46M	Sell	20,364 -1,058	-5%	-$303K	0.74%	18
2015 Q4	$6.69M	Sell	21,422 -344	-2%	-$102K	0.93%	14
2015 Q3	$5.92M	Buy	21,766 +3,748	+21%	+$1.15M	0.88%	15
2015 Q2	$5.47M	Sell	18,018 -623	-3%	-$186K	0.88%	15
2015 Q1	$5.55M	Buy	18,641 +1,970	+12%	+$562K	0.91%	15
2014 Q4	$4.32M	Buy	16,671 +132	+0.8%	+$33K	0.7%	19
2014 Q3	$3.99M	Sell	16,539 -1,244	-7%	-$278K	0.7%	17
2014 Q2	$3.97M	Buy	17,783 +116	+0.7%	+$24K	0.75%	16
2014 Q1	$3.64M	Sell	17,667 -6,203	-26%	-$1.23M	0.73%	16
2013 Q4	$20.7M	Buy	23,870 +12,392	+108%	+$1.94M	0.77%	29
2013 Q3	$1.65M	Hold	11,478	–	–	0.36%	44
2013 Q2	$1.45M	Buy	+11,478	New	+$1.3M	0.35%	48

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Gerstein Fisher's AGN Position: Q3 2016 in Review

Gerstein Fisher reduced its Allergan plc (AGN) stake by 1.6% in Q3 2016, selling an estimated $73.6K and leaving 19,009 shares worth $4.38M. The position accounts for 0.54% of the portfolio, ranked #30.

Gerstein Fisher first reported a position in AGN in Q2 2013 and has held it in 14 quarters since. The position peaked at $20.7M in Q4 2013. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

Gerstein Fisher held 19,009 shares of Allergan plc worth $4.38M as of Q3 2016.
Gerstein Fisher sold 301 Allergan plc shares in Q3 2016, an estimated $73.6K.
Allergan plc made up 0.54% of Gerstein Fisher's portfolio in Q3 2016, its #30 holding.
Gerstein Fisher first reported a position in Allergan plc in Q2 2013 and has held it in 14 quarters since.
Gerstein Fisher's Allergan plc position peaked at $20.7M in Q4 2013.
1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Gerstein Fisher's 13F filing for Q3 2016, filed 15 Nov 2016.